Abstract − Analytical Sciences, 29(9), 871 (2013).
Protein-based Open Sandwich Immuno-PCR for Sensitive Detection of Small Biomarkers
  Sharif HASAN,* Jinhua DONG,** Yuko HARA,*,** Yoshihito MORIZANE,*** Futoshi SHIBASAKI,*** and Hiroshi UEDA*,**
  *Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113–8656, Japan
**Chemical Resources Laboratory, Tokyo Institute of Technology, 4259-R1-18, Nagatsuta-cho, Midori, Yokohama, Kanagawa 226–8503, Japan
***Department of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156–8506, Japan
  **Chemical Resources Laboratory, Tokyo Institute of Technology, 4259-R1-18, Nagatsuta-cho, Midori, Yokohama, Kanagawa 226–8503, Japan
***Department of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya, Tokyo 156–8506, Japan
Open sandwich (OS) immunoassay utilizes antigen-dependent stabilization of an antibody variable region to quantify various antigens, enabling noncompetitive detection of small molecules with a broad working range.  For further improvement of its sensitivity, OS Immuno-PCR was attempted with recombinant fusion proteins.  The maltose binding protein-fused heavy chain variable region (MBP-VH) of an antibody that recognizes the C-terminal fragment of human osteocalcin (bone Gla protein, BGP), a biomarker for bone-related diseases, was immobilized onto microplate wells, and the antigen together with streptavidin (SA)-fused light chain variable region of the same antibody (SA-VL) was added and incubated.  The amount of immobilized SA-VL was quantified by tethered biotinylated DNA, which was used to estimate the amount of antigen by realtime PCR.  When BGP C-terminal peptide was detected, the limit of detection was 100 fg/mL, which was superior than that of our previously reported phage-based OS Immuno-PCR.  The developed OS Immuno-PCR system will be useful for the detection of small molecule biomarkers for disease prevention.
  
    J-STAGE: 
View this article in J-STAGE
  
 Back to the Table of Contents
 Back to the Table of Contents
